The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19

Basit Öğe Kaydı
dc.contributor.authorYildiz, Yesim
dc.contributor.authorOzger, Hasan Selcuk
dc.contributor.authorAcar, Ali
dc.contributor.authorSeremet-Keskin, Aysegul
dc.contributor.authorBinay, Umut Devrim
dc.contributor.authorUnlu, Gulten
dc.contributor.authorBayram, Halim
dc.date.accessioned2024-04-24T17:20:55Z
dc.date.available2024-04-24T17:20:55Z
dc.date.issued2023
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as 'fully' and 'partially' vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group's need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.en_US
dc.identifier.doi10.36519/idcm.2023.216
dc.identifier.endpage126en_US
dc.identifier.issn2667-646X
dc.identifier.issue2en_US
dc.identifier.pmid38633011
dc.identifier.startpage118en_US
dc.identifier.trdizinid1183916
dc.identifier.urihttps://doi.org/10.36519/idcm.2023.216
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1183916
dc.identifier.urihttps://hdl.handle.net/11468/19301
dc.identifier.volume5en_US
dc.identifier.wosWOS:001138794000007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherDoc Design Informatics Co Ltden_US
dc.relation.ispartofInfectious Diseases and Clinical Microbiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19 Vaccineen_US
dc.subjectIntensive Care Uniten_US
dc.subjectRisk Factoren_US
dc.subjectSars-Cov-2 Infectionen_US
dc.subjectVaccine Breakthrough Infectionsen_US
dc.subjectVariant Of Concernsen_US
dc.titleThe Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19en_US
dc.titleThe Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu